American Journal of Cardiology

Cardiology

One antiplatelet drug after heart valve replacement

Current treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots.

Cardiology

Obesity might raise your risk for A-fib

(HealthDay)—Obese people are at increased risk for the heart rhythm disorder atrial fibrillation, which can cause complications such as heart failure and stroke.

Cardiology

Cardiopulmonary exercise testing prognostic in aortic stenosis

(HealthDay)—For patients judged as symptomatic or questionably symptomatic for aortic stenosis, an initially conservative management strategy results in good prognosis if cardiopulmonary exercise testing (CPET) does not ...

Cardiology

Worse LV global longitudinal strain for STEMI with COPD

(HealthDay)—For patients with ST-segment elevation myocardial infarction (STEMI), those with chronic obstructive pulmonary disease (COPD) have significantly more impaired left ventricular (LV) global longitudinal strain ...

Cardiology

Rivaroxaban OK for stroke prevention in cancer patients

(HealthDay)—The safety and efficacy of rivaroxaban treatment for nonvalvular atrial fibrillation (AF) in patients with active cancer is similar to the general population, according to a study published in the July 15 issue ...

page 3 from 24